Gluten-Free Diet in Patients Diagnosed With Diarrhea-Predominant Irritable Bowel Syndrome
07/17/07 11:18 AM
|
|
|
|
Heather
Reged: 12/09/02
Posts: 7799
Loc: Seattle, WA
|
|
|
Predictors of Clinical Response to Gluten-Free Diet in Patients Diagnosed With Diarrhea-Predominant Irritable Bowel Syndrome
Ulrich Wahnschaffe, , , Jörg–Dieter Schulzke‡, Martin Zeitz‡ and Reiner Ullrich‡
‡Medical Clinic I (Gastroenterology/Infectious diseases/Rheumatology), Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany
Medical Clinic A, Department of Gastroenterology, Endocrinology and Nutritrion, University Hospital Ernst Moritz Arndt Universität Greifswald, Greifswald, Germany
Refers to: Exam 2: Predictors of Clinical Response to Gluten-Free Diet in Patients Diagnosed With Diarrhea-Dominant Irritable Bowel Syndrome
Clinical Gastroenterology and Hepatology, Volume 5, Issue 7, July 2007, Page 769
U. Wahnschaffe
Background & Aims: Gluten sensitivity might cause abdominal symptoms in the absence of villous atrophy. We examined the prevalence of celiac disease–associated serum antibodies in diarrhea-dominant irritable bowel syndrome (d-IBS) patients and their efficacy in combination with HLA-DQ2 expression to predict the response to gluten-free diet.
Methods: HLA-DQA1*0501/DQB1*0201 expression and celiac disease–associated IgA and IgG serum antibodies against gliadin and tissue-transglutaminase were measured in 145 patients with d-IBS, 74 patients with untreated and treated celiac disease, and 57 patients with active IBD. Follow-up antibody levels, stool frequency, and gastrointestinal symptom scores were determined in 41 d-IBS patients (26 women, 15 men; median age, 46 years, range, 30–67 years) who participated in a nonrandomized evaluation of 6 months of gluten-free diet.
Results: Increased celiac disease–associated serum IgG, but not IgA, was found in the majority of patients with treated (55%) as in most patients with untreated celiac disease (97%). In d-IBS patients, celiac disease–associated serum IgG antibodies (37%) and HLA-DQ2 expression (39%) were more frequent than in IBD patients (18% and 23%, respectively). After 6 months of gluten-free diet, stool frequency and gastrointestinal symptom score returned to normal values in 60% of d-IBS patients who were positive and in 12% who were negative for HLA-DQ2 and celiac disease–associated serum IgG; both parameters combined yielded positive and negative predictive values of 56% (95% confidence interval, 30%–80%) and 88% (69%–97%), respectively.
Conclusions: Celiac disease–associated serum IgG and HLA-DQ2 expression can identify likely responders to gluten-free diet in d-IBS patients.
Clinical Gastroenterology and Hepatology
Volume 5, Issue 7, July 2007, Pages 844-850
--------------------
Heather is the Administrator of the IBS Message Boards. She is the author of Eating for IBS and The First Year: IBS, and the CEO of Heather's Tummy Care. Join her IBS Newsletter. Meet Heather on Facebook!
Print
Remind Me
Notify Moderator
|
|
Posts
